Clearpoint Neuro, Inc. balance sheet

At the end of fiscal 2025, Clearpoint Neuro, Inc. had total assets of $97.7m, total liabilities of $69.7m and shareholders' equity of $28.0m. It held $45.9m in cash against $50.9m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Clearpoint Neuro, Inc.: balance sheet, annual
Fiscal year	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Cash and equivalents	2	0	2	4	9	5	3	9	3	6	20	54	28	23	20	46	46
Receivables	—	0	0	1	0	1	1	1	1	1	2	2	3	3	5	7	8
Inventory	—	1	1	1	2	2	2	2	2	3	3	5	9	8	7	8	10
Total current assets	—	2	3	6	12	9	6	13	7	10	25	62	51	36	33	64	67
Goodwill	—	—	—	—	—	—	—	—	—	—	—	—	—	—	7	7	7
Total assets	—	3	6	8	13	10	7	14	8	12	30	66	55	43	39	98	113
Accounts payable	—	4	2	1	1	1	2	1	1	1	0	0	0	0	1	1	1
Deferred revenue (current)	—	—	0	0	0	0	0	0	0	1	1	1	1	3	2	2	2
Total current liabilities	—	15	6	10	5	8	3	4	2	4	3	5	7	7	10	11	10
Short-term debt	—	—	—	—	—	4	—	2	—	—	—	—	—	—	—	—	—
Long-term debt	—	0	2	4	11	8	4	5	3	2	21	10	10	10	0	49	51
Total debt	0	7	2	4	11	11	7	7	5	3	25	10	10	10	0	51	53
Total liabilities	—	25	13	15	13	12	8	8	6	7	27	17	19	21	14	70	85
Shareholders' equity	−15	−22	−8	−7	−0	−2	−1	6	2	5	2	49	37	21	25	28	27
Shares outstanding	—	—	—	—	—	2m	—	—	11m	15m	17m	24m	25m	25m	28m	29m	32m

US$ millions unless shown otherwise. Fiscal quarters.

Clearpoint Neuro, Inc.: balance sheet, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Receivables	5	4	4	4	7	9	8	8
Inventory	7	7	6	7	8	9	9	10
Total current assets	33	24	54	51	64	55	49	67
Goodwill	7	—	—	—	7	7	7	7
Total assets	39	30	63	60	98	93	87	113
Accounts payable	1	1	2	1	1	2	2	1
Deferred revenue (current)	2	2	1	2	2	2	2	2
Total current liabilities	10	7	7	8	11	9	10	10
Long-term debt	0	—	29	29	49	50	50	51
Total debt	0	—	29	29	49	50	50	51
Total liabilities	14	10	43	44	70	75	76	85
Shareholders' equity	25	20	20	16	28	19	11	27
Shares outstanding	28m	28m	28m	28m	29m	30m	31m	32m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CLPT vs KRMD CLPT vs TLSI CLPT vs SNWV CLPT vs SENS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Clearpoint Neuro, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Clearpoint Neuro, Inc.